The value of the old and the new
P Monagle, C Male, L Raffini - Blood Advances, 2023 - ashpublications.org
The American Society of Hematology (ASH) guidelines on treatment of pediatric venous
thromboembolism (VTE) published in 2018, 1 were landmark pediatric guidelines for a …
thromboembolism (VTE) published in 2018, 1 were landmark pediatric guidelines for a …
Acute management of childhood stroke
MG Chung, L Pabst - Current Opinion in Pediatrics, 2023 - journals.lww.com
Acute management of childhood stroke : Current Opinion in Pediatrics Acute management of
childhood stroke : Current Opinion in Pediatrics Log in or Register Subscribe to journalSubscribe …
childhood stroke : Current Opinion in Pediatrics Log in or Register Subscribe to journalSubscribe …
[HTML][HTML] New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline
C Weimar, J Beyer-Westendorf, FO Bohmann… - … Research and Practice, 2024 - Springer
Over the last years, new evidence has accumulated on multiple aspects of diagnosis and
management of cerebral venous and dural sinus thrombosis (CVT) including identification of …
management of cerebral venous and dural sinus thrombosis (CVT) including identification of …
[HTML][HTML] Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review
Cerebral venous thrombosis is a rare cause of stroke in young mostly female adults which is
frequently overlooked due to its variable clinical and radiological presentation. This review …
frequently overlooked due to its variable clinical and radiological presentation. This review …
[PDF][PDF] Addendum to British Society for Haematology guideline on the investigation, management and prevention of venous thrombosis in children (Br. J. Haematol …
TT Biss, EA Chalmers - Br. J. Haematol., 2021 - bsh.org.uk
Options for the prevention and treatment of venous thromboembolism (VTE) in childhood
have largely been limited to oral vitamin K antagonists (VKA), injectable low molecular …
have largely been limited to oral vitamin K antagonists (VKA), injectable low molecular …
Direct oral anticoagulants: overcoming the challenges of managing venous thromboembolism in children
C Male, P Monagle, M Albisetti, LR Brandão… - The Journal of …, 2022 - jpeds.com
Christoph Male, MD1, Paul Monagle, MD2, 3, Manuela Albisetti, MD4, Leonardo R.
Brandao, MD5, 6, and Guy Young, MD7 Venous thromboembolism (VTE), including deep …
Brandao, MD5, 6, and Guy Young, MD7 Venous thromboembolism (VTE), including deep …
Venous Thromboembolism in Children: The Rivaroxaban Experience
L Spiezia, E Campello, D Tormene… - … in Thrombosis and …, 2024 - thieme-connect.com
The incidence of venous thromboembolism (VTE) in the pediatric population has increased
more than 10-fold in the last 20 years, as a consequence of the advancement of …
more than 10-fold in the last 20 years, as a consequence of the advancement of …
Guidelines on the prevention and treatment of venous thromboembolism in cancer patients treated surgically, including patients under 18 years of age
Z Krasiński, T Urbanek, A Undas… - Acta …, 2021 - journals.viamedica.pl
Venous thromboembolism (VTE) is one of the most dangerous complications of cancer.
Oncological treatment, surgeries and advanced-stage cancer are only some of the risk …
Oncological treatment, surgeries and advanced-stage cancer are only some of the risk …
Efficacy and Safety of Direct Oral Anticoagulants in Cerebral Venous Thrombosis: Meta-Analysis of Randomized Clinical Trials
X Chen, L Guo, M Lin - Clinical and Applied Thrombosis …, 2024 - journals.sagepub.com
Current guidelines recommend the standard-of-care anticoagulation (vitamin K antagonists
or low-molecular-weight heparin) in patients with cerebral venous thrombosis (CVT). Herein …
or low-molecular-weight heparin) in patients with cerebral venous thrombosis (CVT). Herein …
Direct oral anticoagulants compared to warfarin in long‐term management of cerebral venous thrombosis: A comprehensive meta‐analysis
R Ranjan, G Ken‐Dror, P Sharma - Health Science Reports, 2024 - Wiley Online Library
Objectives We compared the safety and efficacy of direct oral anticoagulants (DOACs) with
those of warfarin in the long‐term (≥ 6 months) treatment of cerebral venous thrombosis …
those of warfarin in the long‐term (≥ 6 months) treatment of cerebral venous thrombosis …